Treatment for inflammatory bowel disease

Details for Australian Patent Application No. 2010333892 (hide)

Owner Sanofi

Inventors Minnich, Anne; Bekasi, Eszter; ChoiSledeski, Yong Mi

Agent Watermark

Pub. Number AU-A-2010333892

PCT Pub. Number WO2011/078983

Priority 1057198 10.09.10 FR; 61/289,596 23.12.09 US

Filing date 13 December 2010

Wipo publication date 30 June 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/06 Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 Medicinal preparations characterised by special physical form - Dispersions

A61K 9/12 Medicinal preparations characterised by special physical form - Aerosols

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/404

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/078983 Priority application(s): WO2011/078983

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333893-[4[4-(5-aminomethyl-2-fluoro-phenyl)- piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)- methanones and synthesis thereof

2010333884-Selection and presentation of related social networking system content and advertisements